PsyLabs is one of the world’s leading manufacturers of pharmaceutical-grade psilocybin, operating a federally licensed cultivation, production, and export facility in Southern Africa. The company combines advanced mushroom cultivation with proprietary extraction, purification, and stabilisation technologies to produce highly purified active pharmaceutical ingredients (APIs) for the global medical and research markets.
Operating to internationally recognised quality standards, PsyLabs supplies pharmaceutical-grade psilocybin to researchers, healthcare innovators, and pharmaceutical partners across multiple countries, including Canada, the United Kingdom, Portugal, Australia, and Slovenia. Through its focus on scientific excellence, regulatory compliance, and scalable production, PsyLabs is helping to advance the development of next-generation psychedelic therapeutics worldwide.
